Clinical Trials Browser

Phase 2 × emibetuzumab × Gastrointestinal × Clear all

NCT01874938 2015-01-16

A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms